🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Last week, the House passed a $9.4 billion rescissions package - and it's bad news for foreign assistance programs that make America safer, stronger & more prosperous. What are rescissions? Why is ONE asking Senators to reject these cuts? How can you help? All that, and more:

According to a UNAIDS Global analysis, ending PEPFAR-supported programs for people living with HIV could result in an additional 4.2 million deaths by 2029: b-gat.es/4lbD4Lw

Former Senate Majority Leader and physician Bill Frist, M.D. makes a clear case for why Congress should maintain support for life-saving programs like PEPFAR: "A $400 million rescission from Congressionally-approved PEPFAR funds doesn’t improve our global position — rather it makes us

What's new in #GlobalHealth R&D? 💊Non-TB mycobacteria drug 🔬New antifungal discovery 🦟#Malaria parasite research

Call for Late-Breaker Abstracts for the Annual Meeting. Deadline: July 23. These are brief presentations of new data obtained after the closing date for abstract submission. tinyurl.com/5b59mtpr

Cuts to USAID are already being deeply felt. A new study links the agency's lifesaving work to a 15% reduction in global mortality over 21 years, with notable effects in reducing deaths from HIV/AIDS (65%), malaria (51%), and NTDs (50%). washingtonpost.com/world/2025/07/…

📢Press release: The antimalarial toolbox just expanded, bringing hope to the smallest patients. The first #malaria treatment for newborns and young infants has been approved by Swissmedic, with fast-track approvals expected across Africa.

Last week, BioVersys AG announced a new agreement with Shionogi to jointly develop its novel drug for treating non-tuberculosis mycobacteria, which affects approximately 250,000 people per year, primarily in North America and Asia.

While its work remained unfamiliar to many Americans, USAID played a key role in saving lives around the world—and it has made Americans safer from disease threats, strengthened America's influence, and driven American innovation & prosperity. ghtcoalition.org/blog/global-he…

🚨 ASM returns to China for the 2025 Global Research Symposium! Join us Nov 18–21 in Shenzhen to explore innovation in synthetic biology, AI and more. Abstracts and registration are now open! asm.social/2uu #SyntheticBiology #AIinScience #EnvironmentalMicrobiology

🌟 Who will be our 2026 Research!America Advocacy Awardees? 🏆 Take a look at the award descriptions and submit your nominations: researchamerica.org/advocacy-award… But hurry! There are only a few weeks left to submit a nomination. The deadline is July 31. #RAAwards #NominateNow

📢 Be sure to catch us at IAS - the International AIDS Society #IAS2025 next week! Christian Onyia will present on the acceptability & challenges of accessing oral PrEP through pharmacies in Nigeria & share findings on how community pharmacies can reach vulnerable populations: bit.ly/4nKs0H9

USAID supported the development of new tools that could transform efforts against diseases like TB & new threats. US global health funding cuts could lead to rising TB in the US & globally and disrupt the development of tools for a host of health threats. usatoday.com/story/opinion/…

IVI and Vaccinopolis UAntwerpen partner to advance vaccine R&D for global health. Combining our complementary expertise in epidemiology, translational clinical research, and capacity-building, we aim to accelerate the development of safe, effective, and affordable vaccines.

Scientists at King’s College London have developed a new class of antifungal compounds that could lead to a promising new tool against Candida auris, a dangerous fungal pathogen and a growing global threat.

⏰ Last chance to register! Don’t miss out on the next Journal of Virology Seminar Series on July 21 at 1 p.m. ET diving into how giant viruses outsmart one another to dominate their host. 👉 Register now: asm.social/2ux 📄 Read the paper: asm.social/2uy

#Mycetoma causes severe suffering but remains overlooked, under-researched & underfunded. Join us & World Health Organization (WHO) for a webinar on why advancing research & prevention is urgent, especially after the loss of Sudan’s Mycetoma Research Center. 🗓️16.07 🕑2–4 PM GMT+3 Registration: who-e.zoom.us/meeting/regist…

A new long-acting approach to #HIV prevention could prevent 45% of new infections in the US & 28% of those in low- and middle-income countries. That’s the power of #GlobalHealth R&D. #Innovate4Health

As the U.S. reorients its foreign aid strategy, including cutting funding for PEPFAR & USAID, we are seeing HIV cases globally as the supplies of key tools dry up. Further proposed cuts could result in 750k additional AIDS deaths globally next year. wsj.com/world/africa/u…

Vaccines have been a transformative tool, helping reduce child deaths & end the COVID-19 pandemic. Now is the time to double down by improving access & investing in research to develop new vaccines for threats, new & old. #VaccinesWork #VaccinesSaveLives who.int/news/item/24-0…